HWI Global Develops Software System for Stem Cell Labs to Meet GMP Guidelines

www.investorstemcell.com

HWI Global Develops Software System for Stem Cell Labs to Meet GMP Guidelines
Expects to Implement C3 SmartRoom Control Technology in Stem Cell Industry

By: Marketwire .
May. 19, 2011 09:25 PM

PITTSBURGH, PA — (Marketwire) — 05/19/11 — HWI Global, Inc. (OTCBB: IVTW), the Pittsburgh-based clean-room design builder, reports developing high-level Manufacturing Execution System (MES) software combining complete environmental control with real-time monitoring and reporting in accordance with GMP Guidelines and Federal statute 24CFR11. The MES software package is part of HWI’s patent-pending C3 SmartRoom Information Management Solution.

HWI’s MES system complies with 24 CFR Part 11 requiring electronic systems to discern invalid or altered records and secure, computer-generated, time-stamped audit trails. The system independently records the date and time of operator entries and actions that create, modify, or delete electronic records which do not obscure previously recorded information.

The Company recently completed two projects for Stemnion, Inc., a regenerative medicine stem cell firm. Acknowledging various world-wide regulatory bodies are continuously setting guidelines which require timely updates, HWI is keeping in step with the scientific developments and changing attitudes in society.

Deric A. Haddad, CEO, HWI Global explains: “Historically, GMPs have been used to establish quality standards for the manufacturing of pharmaceuticals and medicinal products to ensure drugs and vaccines have consistent quality. Current GMP guidelines are based on the standards that pharmaceutical and healthcare manufacturers have been using for decades. But, with the emergence of stem cell research, new questions have been raised about how to best maintain that quality.”

“Regenerative medicine therapies use different techniques — like tissue engineering. This can involve lab-grown or genetically modified cells — living cells — that cannot be implemented in the same way as a conventional medical product. A different set of standards, a more flexible but accurate validation system is required. Our C3 SmartRoom with the MES software is exactly what they need as it provides automated validation to support that their lab and process have remained in compliance. Whether it is regulatory compliance with the Food and Drug Administration (FDA), the European Medicines Agency (EMA), or any of the countries that use GMP guidelines provided by the World Health Organization, the C3 SmartRoom system is a global solution for validation in this growing, but very diverse, market.”

About HWI Global

HWI Global is a leader in clean-room design engineering and construction, servicing clients in the Life Science, Health Science, Nanotechnology, Microelectronics and Aerospace industries. HWI Global and its network of subject matter experts (SME) — from leading architects, engineers, facilities planners, and specialized installers — effectively design and construct the most state-of-the-art clean environments in a “turnkey” fashion.

http://hwicleanrooms.com/

Safe Harbor Statements

This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions. This press release shall not constitute an offer to issue or sell, or the solicitation of an offer to buy securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

IVTW is a member of EquityGroups The Investors Social Network

Investor Relations:
Mark Kabbash
646-408-2661
mark.kabbash@equitygroups.com
or
Media Relations:
Jerry Jennings
561-881-7318
jerry@emersongerard.com